This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Elsevier Announces Launch Of New Journal: Current Opinion In Insect Science

Stocks in this article: REN ENL RUK

NEW YORK, July 14, 2014 /PRNewswire/ --

First published articles now available for free online on ScienceDirect 

How does oxygen control insect body size? What influence does genetics have on insects' social structure? Articles published in the first issue of Current Opinion in Insect Science - launched today - aims to answer these and more questions.

Current Opinion in Insect Science is the latest title in Elsevier's Current Opinion journal series. It is a review journal that aims to provide specialists with a unique platform to keep up-to-date with the expanding volume of information published in the field of insect science. First articles published are now available for free on ScienceDirect.

Professor David Denlinger ( Ohio State University, Columbus, OH, USA) and Dr. Jeff Harvey (Netherlands Institute of Ecology) lead the editorial board.

"Initially I was reluctant to launch a new journal as there are so many out there already," said Denlinger. "I soon realized the unique niche defined by Elsevier's Current Opinion series however. This addition to the series offers an exciting way to keep the growing community of insect scientists up to date on diverse hot topics affecting our field."

"Following the success of the Molecular Insect Science conference held in Amsterdam in 2011, we started to develop the idea of a new Current Opinion title that could encompass the expanding amount of research in the insect science discipline," said Dale Seaton, Executive Publisher Biological Sciences at Elsevier. "With David and Jeff's leadership we have assembled a series of topical reviews from the world's leading scientists that will provide essential reading updates for the insect research community."

The first issue of Current Opinion in Insect Science is available for free on ScienceDirect

For more information about Current Opinion in Insect Science, or to submit an article, go to: http://www.elsevier.com/locate/cois

About the editors 

David Denlinger is a Distinguished University Professor at the Ohio State University. He has published more than 300 peer-reviewed articles and has co-edited several books. He was the co-editor of the Journal of Insect Physiology. Denlinger's recent research has focused on molecular and physiological mechanisms regulating insect diapause and cold hardiness.

Jeff Harvey is a senior scientist at the Netherlands Institute of Ecology and former Associate Editor of Nature. Harvey's research focuses on life history strategies in parasitoids and hyperparasitoids, plantherbivore-parasitoid interactions and community ecology; science and advocacy.

About Elsevier 

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions - among them ScienceDirect, Scopus, Elsevier Research Intelligence, and ClinicalKey - and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.

The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact Jason Awerdick Elsevier +1-212-633-3103 j.awerdick@elsevier.com

SOURCE Elsevier

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 18,053.71 +23.50 0.13%
S&P 500 2,088.77 +6.89 0.33%
NASDAQ 4,806.8590 +33.3870 0.70%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs